Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

<p>Demographics and Baseline Characteristics</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Cloud P. Paweletz (14960112) (author)
Altres autors:	Grace A. Heavey (16495683) (author), Yanan Kuang (16495686) (author), Emily Durlacher (16495689) (author), Thian Kheoh (16495692) (author), Richard C. Chao (16495695) (author), Alexander I. Spira (16495698) (author), Konstantinos Leventakos (16495701) (author), Melissa L. Johnson (16019536) (author), Sai-Hong Ignatius Ou (15023025) (author), Gregory J. Riely (14961725) (author), Kenna Anderes (15123501) (author), Wenjing Yang (16495704) (author), James G. Christensen (15123507) (author), Pasi A. Jänne (14954872) (author)
Publicat:	2025
Matèries:	Cancer Clinical Research and Trials Methods and Technology Imaging Liquid Biopsy Precision Medicine
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars